U.S. Markets closed

pSivida Corp. (PSDV)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.22+0.09 (+4.23%)
At close: 4:00PM EDT
People also watch
ALIMPRANOPXAPSTIBDSI
Interactive chart
Previous Close2.13
Open2.14
Bid2.03 x 4000
Ask2.30 x 500
Day's Range2.10 - 2.22
52 Week Range1.50 - 4.25
Volume536,765
Avg. Volume383,125
Market Cap87.37M
Beta-1.75
PE Ratio (TTM)-4.05
EPS (TTM)-0.55
Earnings DateMay 3, 2017 - May 8, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.83
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to pSivida Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube17 days ago

    ETFs with exposure to pSivida Corp. : May 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017
    Capital Cube18 days ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., Abbott Laboratories, Merck & Co., Inc. and Pfizer Inc. (REGN-US, ALIM-US, ABT-US, MRK-US and PFE-US) that have also reported for ... Read more (Read more...)